Rare Gene Mutation Rewires Developmental Programs in Alazami Syndrome, Revealing Cardiac Risk

In a finding that could reshape how clinicians think about one of the rarest neurodevelopmental disorders on record, a team of geneticists in the United Arab Emirates has identified a never-before-seen mutation in the LARP7 gene and, in doing so, has pushed the boundaries of Alazami syndrome into uncharted cardiac territory. The six-year-old boy at the center of the study carried a novel homozygous frameshift variant that wiped out nearly all functional LARP7 protein, and he presented with tetralogy of Fallot, a complex congenital heart defect that had never previously been reported in association with the disorder. The discovery, published in Frontiers in Cell and Developmental Biology, is more than a clinical curiosity: it offers the first comprehensive transcriptomic portrait of genetically confirmed LARP7 deficiency in primary human cells, and it points to a molecular storm involving extracellular matrix remodeling, developmental signaling, and immune regulation that may underlie the multisystem devastation of this condition.

Alazami syndrome, first described in 2012, is an autosomal recessive disorder caused by biallelic loss-of-function variants in LARP7, a gene that encodes a critical scaffold protein of the 7SK small nuclear ribonucleoprotein complex. That complex acts as a molecular brake on RNA polymerase II, the enzyme responsible for transcribing protein-coding genes, by sequestering the positive transcription elongation factor b, or P-TEFb. When LARP7 is lost, the 7SK snRNP disintegrates, P-TEFb activity is disrupted, and the finely tuned choreography of transcriptional pause-release goes awry. The clinical consequences are severe: affected individuals typically present with profound intellectual disability, proportionate short stature, microcephaly, and a distinctive craniofacial appearance marked by a broad nose, deep-set eyes, and a triangular face. Until now, congenital heart disease had only rarely been described in the syndrome, and tetralogy of Fallot, a four-part malformation of the heart’s outflow tract, had never been documented.

The proband in the new study was born to consanguineous parents from the same Emirati tribe sharing Yemeni ancestry. Within twelve hours of birth, he developed cyanosis and hypoxemia, and echocardiography confirmed classical tetralogy of Fallot with severe pulmonary stenosis at multiple levels. He underwent a modified Blalock–Taussig shunt at four weeks of age and complete surgical repair at thirteen months. Beyond the cardiac crisis, the boy exhibited the hallmarks of Alazami syndrome: severe postnatal growth restriction with height and weight persistently below the third percentile, global developmental delay with an IQ of 53, failure to thrive requiring prolonged nasogastric feeding, and distinctive dysmorphic features including slanting palpebral fissures, hypertelorism, an upturned nose, and a small mouth. He also had microphthalmia with microcornea, large-angle esotropia, and bilateral myopia. Fluorescence in situ hybridization testing for the 22q11.2 deletion associated with DiGeorge syndrome was negative, ruling out the most common genetic cause of tetralogy of Fallot.

To identify the genetic culprit, the team performed trio exome sequencing on blood-derived genomic DNA from the proband and his parents. The analysis revealed a novel homozygous two-nucleotide insertion in LARP7, designated c.618_619insTT, which introduces a frameshift at codon 207 and generates a premature stop codon seven residues downstream. The variant was absent from population databases including gnomAD and had never been reported in the clinical literature. Both parents were confirmed heterozygous carriers, consistent with autosomal recessive inheritance, and no other pathogenic variants were detected in established congenital heart disease genes such as NOTCH1, NKX2-5, TBX1, or JAG1. The finding was validated by Sanger sequencing, which demonstrated complete co-segregation within the family.

Functional confirmation came from patient-derived dermal fibroblasts, which the researchers cultured under standardized conditions alongside fibroblasts from an unrelated healthy Emirati control. Quantitative PCR revealed an approximately 85 percent reduction in LARP7 transcript levels in the patient’s cells, a finding consistent with nonsense-mediated mRNA decay triggered by the frameshift mutation. Western blotting went further: while control fibroblast lysates showed a clear immunoreactive LARP7 band at approximately 75 kilodaltons, the patient’s sample lacked full-length LARP7 entirely, indicating production of a truncated or unstable protein. These results established that the novel variant is a bona fide loss-of-function allele, and they provided the molecular foundation for the transcriptomic investigation that followed.

RNA sequencing of the patient and control fibroblasts generated approximately 22 million paired-end reads per sample, with more than 96 percent of bases scoring above Q20 and more than 97 percent mapping to the human reference genome. Because the study involved a single patient and a single control, the team employed a single-subject differential expression framework, using iDEG modeling to estimate gene-level perturbations and N-of-1 gene set enrichment to infer pathway-level alterations. Out of 12,510 genes detected, 1,224 met the statistical criteria for differential expression. The upregulated genes were dominated by extracellular matrix and developmental remodeling factors, including POSTN, FBN2, IGFBP3, and VCAN, while downregulated genes included developmental signaling regulators such as SFRP1, DUSP4, and DMKN. The variance-stabilized expression data revealed clear separation between patient and control, and the empirical null distribution was centered near zero, supporting the statistical coherence of the single-subject approach.

Pathway enrichment analysis using Gene Ontology Biological Process terms identified 259 significantly upregulated and 145 downregulated pathways. The upregulated clusters converged on proliferative processes, including mitotic cell cycle, chromosome segregation, spindle organization, and DNA metabolic processes, alongside pathways related to supramolecular fiber organization, cell adhesion, and tissue remodeling. In contrast, the downregulated clusters centered on immune signaling, metabolic homeostasis, and developmental differentiation. Network-based prioritization using protein-protein interaction data from STRING identified central hub genes within the upregulated cell-cycle networks, including CDK1, CCNB1, CDC20, and CENPF, while downregulated subnetworks included key immune and metabolic regulators such as STAT3, IL6, TLR4, and CEBPB. The convergence of differential expression, pathway enrichment, and network analysis on three major biological themes, namely activation of extracellular matrix and developmental remodeling programs, upregulation of proliferative modules, and suppression of immune and differentiation-associated signaling, provided a coherent molecular signature of LARP7 deficiency.

The cardiac connection emerged from a careful integration of the transcriptomic findings with established developmental biology. Among the dysregulated genes, several have direct and well-documented roles in cardiac morphogenesis. POSTN, which encodes periostin, is expressed in embryonic endocardial cushions and guides valve and outflow tract development; knockout mice display outflow tract malformations and valve defects that mimic tetralogy of Fallot. DKK1, an inhibitor of Wnt signaling, is expressed by cardiac neural crest cells and regulates second heart field progenitors, and disruption of Wnt signaling causes conotruncal malformations in model systems. FBN2, encoding fibrillin-2, is critical for microfibril assembly and transforming growth factor beta signaling, with mutations causing congenital connective tissue syndromes that include outflow tract anomalies. NTN1, which guides cardiac neural crest cell migration, was downregulated, and loss of netrin signaling is a known mechanism for outflow tract septation defects. SMAD3, a central mediator of transforming growth factor beta signaling in cardiovascular development, was significantly upregulated, and experimental disruption of SMAD-dependent pathways has been associated with conotruncal malformations, septation defects, and abnormal valve formation. Conversely, STAT3, which supports endocardial cushion development and cardiomyocyte survival, was downregulated. The imbalance between STAT3-associated signaling and SMAD3-linked extracellular matrix remodeling identifies a transcriptional perturbation that overlaps with pathways known to participate in outflow tract development.

The researchers are careful to note that the fibroblast transcriptomic findings do not establish a causal relationship with the patient’s tetralogy of Fallot, and they acknowledge the limitations of a single-subject design and the use of dermal fibroblasts rather than cardiac or neural tissue. Nevertheless, the convergence of multiple analytical approaches on biologically coherent pathways, together with the precedent that the developing heart is especially sensitive to disruption of the 7SK snRNP complex, as demonstrated by the fetal cardiac hypertrophy and lethality observed in HEXIM1-deficient models, suggests that cardiac involvement in Alazami syndrome warrants serious clinical attention. The team recommends that individuals with confirmed LARP7 deficiency undergo baseline cardiac evaluation, including echocardiography, to detect congenital or acquired cardiac abnormalities. Beyond the cardiac implications, the transcriptomic signature of LARP7 deficiency raises intriguing questions about cancer predisposition, as thyroid carcinoma has been described in an individual with Alazami syndrome and was also reported in two relatives of the present proband, while several dysregulated genes identified in the study, including MET, IGFBP3, and DUSP4, have been implicated in thyroid tumorigenesis.

This study represents a landmark in the molecular characterization of Alazami syndrome and demonstrates the power of transcriptomic profiling in rare Mendelian disorders. By combining clinical genetics, functional validation, and cutting-edge single-subject bioinformatics, the researchers have not only expanded the phenotypic spectrum of a devastating condition but have also illuminated the transcriptional networks that connect a single gene to the coordinated development of multiple organ systems. As larger cohorts of LARP7-deficient individuals are assembled and complementary functional models, including induced pluripotent stem cell-derived cardiac cells and cardiac organoids, are brought to bear on the question, the molecular insights gleaned from this single remarkable patient may ultimately inform diagnostic strategies, surveillance protocols, and therapeutic interventions for Alazami syndrome and related disorders of transcriptional elongation.

Subject of Research: A novel LARP7 variant expands the phenotypic spectrum of Alazami syndrome and reveals transcriptomic dysregulation of developmental and extracellular matrix pathways

Article Title: A novel LARP7 variant expands the phenotypic spectrum of Alazami syndrome and reveals transcriptomic dysregulation of developmental and extracellular matrix pathways

Article References: A novel LARP7 variant expands the phenotypic spectrum of Alazami syndrome and reveals transcriptomic dysregulation of developmental and extracellular matrix pathways. (n.d.). https://doi.org/10.3389/fcell.2026.1904805

Image Credits: AI Generated

DOI: 10.3389/fcell.2026.1904805

Keywords: novel, LARP7, variant, expands, phenotypic, spectrum, Alazami, syndrome, reveals, transcriptomic, dysregulation, developmental